AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polonio, R. E.
Right arrow Articles by Sperry, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polonio, R. E.
Right arrow Articles by Sperry, J. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2001, p. 3262-3266, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3262-3266.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Eradication of Biofilm-Forming Staphylococcus epidermidis (RP62A) by a Combination of Sodium Salicylate and Vancomycin

Roy E. Polonio,1 Leonard A. Mermel,2 Gregory E. Paquette,3 and Jay F. Sperry1,*

Department of Biochemistry, Microbiology and Molecular Genetics,1 and Clinical Laboratory Science Program,3 University of Rhode Island, Kingston, Rhode Island 02881, and Division of Infectious Diseases, Brown University, and Rhode Island Hospital, Providence, Rhode Island 029032

Received 25 August 2000/Returned for modification 5 January 2001/Accepted 8 August 2001

Staphylococcus epidermidis is a major cause of infections associated with indwelling medical devices. Biofilm production is an important virulence attribute in the pathogenesis of device-related infections. Therefore, elimination of these biofilms is an ideal treatment. Salicylate (5 mM) combined with 1 µg of vancomycin per ml inhibited biofilm formation by S. epidermidis (RP62A) by >= 99.9%. When biofilm-coated polystyrene beads were exposed to 5 mM sodium salicylate and 4 µg of vancomycin per ml (one-half the minimum biofilm eradication concentration), there was a >99.9% reduction in viable count.

* Corresponding author. Mailing address: Department of Biochemistry, Microbiology and Molecular Genetics, University of Rhode Island, Kingston, RI 02881. Phone (401) 874-5900. Fax: (401) 874-2202. E-mail: jsp2116u{at}postoffice.uri.edu.

Antimicrobial Agents and Chemotherapy, November 2001, p. 3262-3266, Vol. 45, No. 11
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.11.3262-3266.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.